SCHEMBL22765331

SCHEMBL22765331

O=C(OCc1ccccc1)N1CCN2CCCC2C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 7/20 0.57
SIGMAR1 Q99720 7/20 0.57
HRH3 Q9Y5N1 3/20 0.57
HTR1A P08908 2/20 0.57
HRH2 P25021 2/20 0.57
HRH1 P35367 2/20 0.57
ADRA2C P18825 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
CHRM1 P11229 2/20 0.56
ALDH1A1 P00352 4/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
HPGD P15428 1/20 0.54
CHRM4 P08173 1/20 0.54
CHRM5 P08912 1/20 0.54
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA1D P25100 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678408 1.00 TMEM97 (0.57) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL5103812 0.96 CHRM1 (0.61) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL29138124 0.95 SMN1; SMN2 (0.56) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL30773875 0.91 SMN1; SMN2 (0.61) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL14529819 0.91 SMN1; SMN2 (0.61) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL28412948 0.89 SMN1; SMN2 (0.53) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL28412743 0.89 SMN1; SMN2 (0.53) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL30668752 0.89 SMN1; SMN2 (0.53) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL28414366 0.88 TMEM97 (0.52) TMEM97SIGMAR1HRH3HTR1AHRH2
SCHEMBL519496 0.88 SMN1; SMN2 (0.50) TMEM97SIGMAR1HRH3HTR1AHRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247298-A2 1-PYRAZOLYL, 5-, 6- DISUBSTITUTED INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME CORP. (US) 2020-12-10 WO disclosed